COMPANY
Potrero Hill Therapeutics
NIH awards 6
- NIH award 5R44DK116450-06 FY2022: $1,069,999 awarded for that fiscal year; activity R44 (SBIR); PI BLITZER, JEREMY; recipient as written: POTRERO HILL THERAPEUTICS, INC., SAN FRANCISCO, CA. Dihydroceramide Desaturase source ↗
- NIH award 5R44DK116450-05 FY2021: $1,069,999 awarded for that fiscal year; activity R44 (SBIR); PI BLITZER, JEREMY; recipient as written: POTRERO HILL THERAPEUTICS, INC., SAN FRANCISCO, CA. Dihydroceramide Desaturase source ↗
- NIH award 2R44DK116450-04 FY2020: $1,069,999 awarded for that fiscal year; activity R44 (SBIR); PI BLITZER, JEREMY; recipient as written: POTRERO HILL THERAPEUTICS, INC., SAN FRANCISCO, CA. Dihydroceramide Desaturase source ↗
- NIH award 5R44DK116450-03 FY2019: $749,999 awarded for that fiscal year; activity R44 (SBIR); PI BLITZER, JEREMY; recipient as written: POTRERO HILL THERAPEUTICS, INC., SAN FRANCISCO, CA. Dihydroceramide Desaturase-1 source ↗
- NIH award 2R44DK116450-02 FY2018: $749,999 awarded for that fiscal year; activity R44 (SBIR); PI BLITZER, JEREMY; recipient as written: POTRERO HILL THERAPEUTICS, INC., SAN FRANCISCO, CA. Dihydroceramide Desaturase-1 source ↗
- NIH award 1R43DK116450-01 FY2017: $225,000 awarded for that fiscal year; activity R43 (SBIR); PI BLITZER, JEREMY; recipient as written: POTRERO HILL THERAPEUTICS, INC., SAN FRANCISCO, CA. Dihydroceramide Desaturase-1 source ↗